IPO Commitment. The Company shall, no later than the date that is seven (7) months following the final Closing Date of the Offering, subject to extension upon the prior written approval of the Required Holders (such date, hereinafter, the “Form S-1 Filing Due Date”), file with or submit confidentially to the SEC a registration statement on Form S-1 (or any successor from thereto) to register and sell Common Stock in an IPO and complete the IPO no later than the date that is the 14 month anniversary of the Form S-1 Filing Due Date, subject to extension upon the prior written approval of the Required Holders.
Appears in 2 contracts
Samples: Securities Purchase Agreement (TFF Pharmaceuticals, Inc.), Securities Purchase Agreement (TFF Pharmaceuticals, Inc.)
IPO Commitment. The Company shall, no later than the date that is seven nine (79) months following the final Initial Closing Date of the OfferingDate, subject to extension upon the prior written approval of the Required Holders (such date, hereinafter, the “Form S-1 Filing Due Date”)Holders, file with or submit confidentially to the SEC a registration statement on Form S-1 (or any successor from thereto) to register and sell Common Stock in an IPO and complete the IPO no later than the date that is the 14 month anniversary of the Form S-1 Filing Due Dateby December 31, 2018, subject to extension upon the prior written approval of the Required Holders.
Appears in 1 contract
Samples: Securities Purchase Agreement (Eton Pharmaceuticals, Inc.)